2Karakoyunlar O,Sivrel E,Tanir N ,et al. High dose octreotide in the management of acute pancreatitis. Hepatogastroenterology, 1999,46 (27):1968-1972.
3Uhl W, Buchler MW, Malfertheiner P, et al. A randomised, double blind,multicenter trial of octreotide in moderate to severe acute pancreatitis.Gut, 1999,45:97 - 104.
4Hanks JB, Kortz WJ, Andersen DK, et al. Somatastatin suppression of canine fasting bile secretion. Gastroenterology, 1983,84 : 130 - 137.
5Weber FH JR, Sears RJ, Kendall B, et al. Effect of ectreotide on human sphincter of Oddi motility following liver transplantation. Dig Dis Sci,1997,42:1168 - 1175.
6Lambiase LR, Forsmark C ,Jadunamdan I, et al. Correlation of pain relief and reduction in fasting serum CCK levels in chronic pancreatitis patients with octreotide. Gastroenterolog, 1993,104 (4): A1435 - 1436.
7Baxter JN, Jenkins SA, Day DW, et al. Effects of somatostatin and a long- acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg, 1985,72(5):382-385.
1R. Maciejewski,F. Burdan,K. Burski,B. Madej,R. Ziemiakowicz,A. D?browski,G. Wallner.Selected biochemical parameters and ultrastructural picture of pancreas due to Ulinastatin treatment of experimental acute pancreatitis[J].Experimental and Toxicologic Pathology.2004(4)
2Ma Tao,Kang Chunsheng,Shao Hongwei,Qi Qinghui,Hu Wenquan.Protective effects of ulinastatin on proliferation and cytokine release of splenocytes from rats with severe acute pancreatitis[].European surgical research Europ?ische chirurgische Forschung Recherches chirurgicales européennes.2006
